Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

'Often mistrusted': UK stats watchdog criticises COVID-19 test data

Published 06/02/2020, 08:20 AM
Updated 06/02/2020, 08:25 AM
© Reuters. Children return to the school as the coronavirus disease (COVID-19) lockdown eases in Fulham, West London

© Reuters. Children return to the school as the coronavirus disease (COVID-19) lockdown eases in Fulham, West London

By Andy Bruce

LONDON (Reuters) - Britain's statistics watchdog chided the government on Tuesday for publishing data on coronavirus tests that it said were "far from complete and comprehensible".

"The aim seems to be to show the largest possible number of tests, even at the expense of understanding," David Norgrove, the head of the UK Statistics Authority (UKSA), wrote in a letter to Health Secretary Matt Hancock.

"It is also hard to believe the statistics work to support the testing programme itself."

Criticism from the independent UKSA is likely to add to questions surrounding the government's handling of a pandemic that has killed almost 50,000 people in the United Kingdom, according to the latest data.

Concerns over the test data first came to light when the government set itself an ambitious target to carry out 100,000 tests per day by the end of April - a goal it said it met.

But in doing so, it included in its figures tests mailed out to people but not necessarily completed.

"This distinction is too often elided during the presentation at the daily press conference, where the relevant figure may misleadingly be described simply as the number of tests carried out," Norgrove said.

The health ministry was not immediately available to comment on Norgrove's letter. Norgrove said it was heartening that health ministry officials were cooperating with regulators to improve their statistics.

But he was clear that they were unacceptable in their current form and that mistakes should not be repeated in data for the new test-and-trace system, he said which needed clear metrics for success.

Hancock, in an earlier letter to Norgrove dated May 27, said he strongly supported transparent and high quality data.

"I think it is important to demonstrate how good, high-quality data can be used to drive forward our response to this virus, and to build confidence and trust in our figures as we do so," Hancock wrote.

In his response, Norgrove said he warmly welcomed Hancock's support for high quality data.

"But the testing statistics still fall well short of its expectations," Norgrove said.

© Reuters. Children return to the school as the coronavirus disease (COVID-19) lockdown eases in Fulham, West London

"It is not surprising that given their inadequacy data on testing are so widely criticised and often mistrusted."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.